UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity

Frontiers in oncology, 2024-04, Vol.14, p.1394393-1394393

2024

Volltextzugriff (PDF)

Daratumumab combinations for patients with newly diagnosed and relapsed multiple myeloma

The Lancet. Haematology, 2023-10, Vol.10 (10), p.e788-e789

2023

Volltextzugriff (PDF)

Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy

British journal of haematology, 2020-10, Vol.191 (2), p.194-206

2020

Volltextzugriff (PDF)

Applying current smouldering myeloma risk models to a UK single‐centre cohort and clinical features at progression

British journal of haematology, 2022-03, Vol.196 (6), p.e63-e66

2022

Volltextzugriff (PDF)

Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4 + PD-1 + Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma

Clinical cancer research, 2020-07, Vol.26 (13), p.3443-3454

2020

Volltextzugriff (PDF)

A young woman with fever and loss of consciousness

BMJ (Online), 2018-12, p.k4363

2018

Volltextzugriff (PDF)

Interesting case of lymphocytosis and splenomegaly

BMJ (Online), 2016-03, Vol.352, p.i1227

2016

Volltextzugriff (PDF)

Bruising and abnormal leucocytes on a blood film--a haematological emergency

BMJ (Online), 2017-03, Vol.356, p.j1164

2017

Volltextzugriff (PDF)

Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience

Leukemia & lymphoma, 2021-12, Vol.62 (14), p.3544-3547

2021

Volltextzugriff (PDF)

Response to ‘Impact of immunosuppression on mortality in critically ill COVID‐19 patients’

British journal of haematology, 2020-11, Vol.191 (3), p.505-506

2020

Volltextzugriff (PDF)

Ascites

British journal of hospital medicine (London, England : 2005), 2015-02, Vol.76 (2), p.C23-C27

2015

Volltextzugriff (PDF)

Co-Operation of MCL-1 and BCL-X L Anti-Apoptotic Proteins in Stromal Protection of MM Cells from Carfilzomib Mediated Cytotoxicity

Blood, 2021-11, Vol.138 (Supplement 1), p.2677-2677

2021

Volltextzugriff (PDF)

Acquisition of 1pLOH-1qGain Is a Frequent Trajectory in Expanding Relapsed/Refractory Myeloma Subclones

Blood, 2023-11, Vol.142 (Supplement 1), p.1999-1999

2023

Volltextzugriff (PDF)

Co-operation of MCL-1 and BCL-X L anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity

Frontiers in oncology, 2024, Vol.14, p.1394393

2024

Volltextzugriff (PDF)

Autophagy Blockade Disrupts Myeloma Cell Recovery from Proteasome Inhibition and Enhances Apoptosis

Blood, 2021-11, Vol.138 (Supplement 1), p.1567-1567

2021

Volltextzugriff (PDF)

NSP-04 Patient Perceptions When Receiving Talquetamab for Triple Class Exposed Relapsed/ Refractory Myeloma: A Thematic Analysis

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S284-S284

2024

Volltextzugriff (PDF)

Abstract 2240: Genomic profiling of smoldering multiple myeloma classifies distinct molecular groups

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2240-2240

2021

Volltextzugriff (PDF)

Developing a Flow Cytometric Signature of Carfilzomib Responsiveness in Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.10106-10107

2022

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

ThemaMultiple Myeloma

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Hematology
(7)
Female
(5)
Male
(5)
Patients
(5)
Junior Doctor
(4)
Oncology
(4)
Aged, 80 And Over
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Bone Marrow
(3)
Middle Aged
(3)
Adult
(2)
Aged
(2)
Blood
(2)
Chemotherapy
(2)
Chest X‐rays
(2)
Covid-19
(2)
Disease Progression
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity

Daratumumab combinations for patients with newly diagnosed and relapsed multiple myeloma

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy

Applying current smouldering myeloma risk models to a UK single‐centre cohort and clinical features at progression

Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4 + PD-1 + Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma

A young woman with fever and loss of consciousness

Interesting case of lymphocytosis and splenomegaly

Bruising and abnormal leucocytes on a blood film--a haematological emergency

Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience

Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial

Response to ‘Impact of immunosuppression on mortality in critically ill COVID‐19 patients’

Ascites

Co-Operation of MCL-1 and BCL-X L Anti-Apoptotic Proteins in Stromal Protection of MM Cells from Carfilzomib Mediated Cytotoxicity

Acquisition of 1pLOH-1qGain Is a Frequent Trajectory in Expanding Relapsed/Refractory Myeloma Subclones

Co-operation of MCL-1 and BCL-X L anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity

Autophagy Blockade Disrupts Myeloma Cell Recovery from Proteasome Inhibition and Enhances Apoptosis

NSP-04 Patient Perceptions When Receiving Talquetamab for Triple Class Exposed Relapsed/ Refractory Myeloma: A Thematic Analysis

High Neoantigen Load Confers a Major Benefit from Autologous Stem Cell Transplantation Compared to Consolidation in Newly Diagnosed Multiple Myeloma

Abstract 2240: Genomic profiling of smoldering multiple myeloma classifies distinct molecular groups

Impact of Autologous Stem Cell Transplant (ASCT) Versus Consolidation on Health-Related Quality of Life (HRQoL) for Patients with Multiple Myeloma Receiving Carfilzomib Maintenance: Results from the Cardamon Trial

Developing a Flow Cytometric Signature of Carfilzomib Responsiveness in Myeloma

Genomic Profiling of Smoldering Multiple Myeloma Classifies Molecular Groups with Distinct Pathogenic Phenotypes and Clinical Outcomes

Upfront Autologous Stem Cell Transplantation (ASCT) Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Consolidation in Transplant-Eligible, Newly Diagnosed (NDTE) Multiple Myeloma (MM): Results of the Cardamon Study According to Cytogenetic Risk

PET-CT for Assessment of Multiple Myeloma Disease Burden and Metabolic Response before and after Carfilzomib-Based Induction, Consolidation and Carfilzomib Maintenance Therapy: Data from the UK NCRI Cardamon Study

Aktive Filter

Suchergebnisse filtern